Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Ariel Aviv"'
Autor:
Yair Herishanu, Neta Goldschmidt, Gilad Itchaki, Yotam Bronstein, Itai Levi, Ariel Aviv, Riva Fineman, Najib Dally, Tamar Tadmor, Aaron Ronson, Uri Abadi, Levi Shvidel, Galia Stemer, Sigi Kay, Chen Glait Santar, Moran Barak, Noa Rivlin, Natalie Kaminsky, Raanan Cohen, Keren Ofek, Jenia Berelovich, Moshe Grunspan, Ohad Benjamini
Publikováno v:
HemaSphere, Vol 7, p e4428024 (2023)
Externí odkaz:
https://doaj.org/article/12416f3e28da45aea43d694ae2636cac
Autor:
Regina Michelis, Lama Milhem, Evleen Galouk, Galia Stemer, Ariel Aviv, Tamar Tadmor, Mona Shehadeh, Lev Shvidel, Masad Barhoum, Andrei Braester
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chronic lymphocytic leukemia (CLL), the most common adult’s leukemia in the western world, is caused in 95% of the cases by uncontrolled proliferation of monoclonal B-lymphocytes. The complement system in CLL is chronically activated at a low level
Externí odkaz:
https://doaj.org/article/86d1abd3b2e449fc931853a9e6765e90
Autor:
Ofir Koren, Ariel Aviv, Moran Avraham Kelbert, Ehud Rozner, Liza Lihtman, Elya Halfin, Yoav Turgeman
Publikováno v:
Clinical Case Reports, Vol 9, Iss 4, Pp 2305-2309 (2021)
Abstract Same clinical entity can have different biology and can behave differently. This must be kept in mind while making therapeutic decisions. Primary effusion lymphoma is a rare and devastating disease with high fatality. Chemotherapy provides l
Externí odkaz:
https://doaj.org/article/611ca662c1da460daf75a01d1117a49e
Autor:
Naseba Naseraldeen, Regina Michelis, Masad Barhoum, Judith Chezar, Tamar Tadmor, Ariel Aviv, Lev Shvidel, Adi Litmanovich, Mona Shehadeh, Galia Stemer, Ety Shaoul, Andrei Braester
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults in the western world. One of the treatments offered for CLL is immunotherapy. These treatments activate various cellular and biochemical mechanisms, using the complement system.
Externí odkaz:
https://doaj.org/article/d8997cdb71184c83bcc753d741f0638f
Autor:
Adir Shaulov, Ariel Aviv
Publikováno v:
Annals of Palliative Medicine. 12:445-447
Autor:
Regina Michelis, Tamar Tadmor, Ariel Aviv, Galia Stemer, Rawan Majdob, Lev Shvidel, Mona Shehadeh, Masad Barhoum, Andrei Braester
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0230033 (2020)
Therapy regimens for Chronic lymphocytic leukemia (CLL) commonly include chemotherapy and immunotherapy, which act through complement-mediated-cytotoxicity (CDC) and other mechanisms. CDC depends on several factors, including the availability and act
Externí odkaz:
https://doaj.org/article/83d32eb526e043c896fe50bbe5c98a3c
Autor:
Regina Michelis, Tamar Tadmor, Masad Barhoum, Mona Shehadeh, Lev Shvidel, Ariel Aviv, Galia Stemer, Najib Dally, Naomi Rahimi-Levene, Mona Yuklea, Andrei Braester
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0209024 (2019)
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the Western world. The therapeutic approach to CLL includes chemotherapeutic regimens and immunotherapy. Complement-mediated cytotoxicity, which is one of the mechanisms activate
Externí odkaz:
https://doaj.org/article/743be5ed296d4aefadcc6a3d0dff0b97
Autor:
Shai Levi, Yotam Bronstein, Neta Goldschmidt, Fortunato Morabito, Tomer Ziv‐Baran, Giovanni Del Poeta, Osnat Bairey, Maria Ilaria Del Principe, Riva Fineman, Francesca Romana Mauro, Odit Gutwein, Gianluigi Reda, Rosa Ruchlemer, Paolo Sportoletti, Luca Laurenti, Lev Shvidel, Marta Coscia, Tamar Tadmor, Marzia Varettoni, Ariel Aviv, Roberta Murru, Andrei Braester, Annalisa Chiarenza, Andrea Visentin, Daniela Pietrasanta, Giacomo Loseto, Antonella Zucchetto, Riccardo Bomben, Jacopo Olivieri, Antonio Neri, Davide Rossi, Gianluca Gaidano, Livio Trentin, Robin Foà, Antonio Cuneo, Chava Perry, Valter Gattei, Massimo Gentile, Yair Herishanu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eda238707d6ceab18fa333132205b65
https://hdl.handle.net/2318/1886734
https://hdl.handle.net/2318/1886734
Publikováno v:
Journal of Cancer Survivorship
Purpose The COVID-19 pandemic presents specific challenges for cancer patients attending oncology treatment. Using a mixed-methods design (convergent parallel design), we aimed to assess the experience, perceptions, and reactions of cancer patients d
Autor:
Ehud Rozner, Ofir Koren, Yoav Turgeman, Elya Halfin, Moran Avraham Kelbert, Liza Lihtman, Ariel Aviv
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 9, Iss 4, Pp 2305-2309 (2021)
Clinical Case Reports, Vol 9, Iss 4, Pp 2305-2309 (2021)
Same clinical entity can have different biology and can behave differently. This must be kept in mind while making therapeutic decisions. Primary effusion lymphoma is a rare and devastating disease with high fatality. Chemotherapy provides limited be